Dose and route of administration determine the efficacy of prophylactic immunotherapy for peanut allergy in a Brown Norway rat model

INTRODUCTION: Allergen-specific immunotherapy (IT) is emerging as a viable option for treatment of peanut allergy. Yet, prophylactic IT remains unexplored despite early introduction of peanut in infancy was shown to prevent allergy. There is a need to understand how allergens interact with the immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sztuk, Tiffany Kirkaldy Spaanager, Rigby, Neil Marcus, Nørskov-Nielsen, Lasse, Koppelman, Stef J., Sancho, Ana Isabel, Knudsen, Niels-Peter Hell, Marsh, Justin, Johnson, Philip, Gupta, Shashank, Mackie, Alan Robert, Larsen, Jeppe Madura, Bøgh, Katrine Lindholm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996042/
https://www.ncbi.nlm.nih.gov/pubmed/36911669
http://dx.doi.org/10.3389/fimmu.2023.1121497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996042/
https://www.ncbi.nlm.nih.gov/pubmed/36911669
http://dx.doi.org/10.3389/fimmu.2023.1121497

Ejemplares similares